Pushing The Limits Of Detection Of Weak Binding Using Fragment Based Drug Discovery: Identification Of New Cyclophilin Binders
C. Georgiou, I. W. McNae, M. A. Wear, H. Ioannidis, J. Michel, M. D. Walkinshaw
This paper identifies novel cyclophilin binders using fragment-based drug discovery and combines X-ray diffraction, SPR, and MD simulations to better characterize weak binding events.
bioRxiv · Jun 15, 2017Biophysics